Browse All

Current Filters

CLEAR FILTER x

TITLE

Quality of Life in Patients with Parkinson's Disease in Latin America: A Systematic Review

Author:Acurio, Karlos   flores gavino, Aldo Paul   Chinchihualpa Paredes, Nathaly   Vascones Roman, Fritz   Rios Garcia, Wagner   Callahuanca, Gonzalo   Calisaya-Madariaga, Irving   guerrero yrena, Miriam Lizeth   Aguilar Alvarez, Luis   Pacheco, Niels   

Session Name:P4: Movement Disorders: Care Models and Patient Perceptions in Movement Disorders  

Topic:Movement Disorders  

Program Number:P4.011  

Author Institution:Universidad Peruana Cayetano Heredia, Cusco, Peru  Universidad Peruana Cayetano Heredia, Lima, Peru  NATIONAL UNIVERSITY SAN LUIS GONZAGA, Ica, Peru  Universidad Nacional de Cajamarca, Cajamarca, Peru  Harvard Medical School, Boston, MA  

Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study

Author:Sarva, Harini   Tagliati, Michele   Poewe, Werner   Stocchi, Fabrizio   Rascol, Olivier   Yardeni, Tami   Lopes, Nelson   Pereira, Jonathan   Espay, Alberto   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.007  

Author Institution:Weill Cornell Medical Center, New York, NY  Cedars-Sinai Medical Center, Movement Disorder Program, Los Angeles, CA  Department of Neurology, Medical University Innsbruck, Innsbruck, Austria  University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy  University of Toulouse 3, University Hospital of Toulouse, INSERM  Clinical Investigation Center CIC1436 Departments of Neurosciences and Clinical Pharmacology and NS-Park/FCRIN network, Toulouse, France  NeuroDerm Ltd. , Rehovot, Israel  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  James J and Joan A Gardner Center for Parkinson’s disease and Movement, University of Cincinnati, Cincinnati, OH  

Quantifying Hemodynamic Lag in Pediatric Patients with Sickle Cell Disease using BOLD MRI

Author:Braban, Andra   Sare, Daniel   Geranmayeh, Fatemeh   Williams, Suzan   Kassner, Andrea   

Session Name:P5: Child Neurology and Developmental Neurology: Neonatal, ICU, and Neurovascular  

Topic:Child Neurology and Developmental Neurology  

Program Number:P5.008  

Author Institution:The Hospital for Sick Children, Toronto, ON, Canada  Imperial College London  Imperial College Healthcare NHS Trust, London, United Kingdom  

Quantitation of Hypocretin Neuropeptides (Orexin-A and -B) in Human Cerebrospinal Fluid via HPLC with MS/MS Detection

Author:Pierce, Anson   Ye, Meng   Palandra, Joe   Hui, Yu   Wu, Jian   Wheeler, Aaron   Wiley, Walter   Woolf, M. Shane   Ismaiel, Omnia   Shah, Kumar   Yuan, Moucun   Mylott, William   Baratta, Mike   

Session Name:P1: Sleep 1  

Topic:Sleep  

Program Number:P1.002  

Author Institution:Takeda Pharmaceuticals, CAMBRIDGE, MA  

A Quantitative Assessment of TRB CDR3-CMV Antigen Chemical Interactions Distinguishes Schizophrenia Patients from Control Patients

Author:Sun, Anthony   Eakins, Rachel   Gozlan, Etienne   Chobrutskiy, Andrea   Chobrutskiy, Boris   Blanck, George   

Session Name:P9: Aging, Dementia, and Behavioral Neurology: Non-AD Dementia Diagnostics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P9.006  

Author Institution:University of South Florida, Morsani College of Medicine, Tampa, FL  University of Maryland School of Medicine, Baltimore, MD  Oregon Health and Science University Hospital, Portland, OR